| For: | Elnaggar M, Abomhya A, Elkhattib I, Dawoud N, Doshi R. COVID-19 and liver diseases, what we know so far. World J Clin Cases 2022; 10(13): 3969-3980 [PMID: 35665122 DOI: 10.12998/wjcc.v10.i13.3969] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i13/3969.htm |
| Number | Citing Articles |
| 1 |
B. N. Levitan, T. V. Serdyukova, V. V. Skvortsov. Liver pathology in COVID-19 after end of pandemic: Modern view of problem. Medical alphabet 2024; (34): 10 doi: 10.33667/2078-5631-2023-34-10-15
|
| 2 |
Nikola Mitrović, Nataša Nikolić, Ana Filipović, Ankica Vujović, Uroš Karić, Miloš Šabanović, Ivana Milošević. The impact of chronic viral hepatitis on COVID-19: Clinical course and risk factors for poor outcome. Medicinska istrazivanja 2024; 57(2): 65 doi: 10.5937/medi57-48691
|
| 3 |
Shahrzad Shoraka, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Amir Ghaemi, Mohammad Reza Zali. SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection. Journal of Clinical Virology Plus 2023; 3(4): 100167 doi: 10.1016/j.jcvp.2023.100167
|
